FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease
By DeECO |
Original Post For Immediate Release: August 31, 2022 Today, the U.S. Food and Drug Administration approved Xenpozyme (Olipudase alfa) for ...
Read More COVID-19 Bivalent Vaccine Boosters
By DeECO |
Original Post The virus that causes COVID-19 changes over time. Keep your protection up to date by getting an updated ...
Read More DEA Warns of Brightly-Colored Fentanyl Used to Target Young Americans
By DeECO |
https://www.dea.gov/press-releases/2022/08/30/dea-warns-brightly-colored-fentanyl-used-target-young-americans
Read More FDA’s Overdose Prevention Framework Aims to Prevent Drug Overdoses and Reduce Death
By DeECO |
Original Post By: Robert M. Califf, M.D., Commissioner of Food and Drugs In 2021, a record number of Americans – more ...
Read More